Immuron (IMRN) Revenue (2016 - 2024)

Immuron (IMRN) recorded quarterly Revenue of -$2612125655.3 billion in Q4 2024, down 110890976120175.95% quarter-over-quarter from $2.4 million in Q4 2023, and down 110890976120175.95% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Revenue (2016 - 2024) Analysis & Trends

Immuron's Revenue history runs 9 years deep, the most recent figure standing at -$2612125655.3 billion for Q4 2024.

  • In Q4 2024, Revenue fell 110890976120175.95% year-over-year to -$2612125655.3 billion; the TTM figure through Dec 2024 stood at -$2612125655.3 billion (down 86383847521610.38% YoY), while the FY2025 annual figure was $4.7 million, up 46.88% from the prior year.
  • Revenue was -$2612125655.3 billion for Q4 2024 at Immuron, down from $2.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $2.4 million in Q4 2023 to a low of -$2612125655.3 billion in Q4 2024.
  • Historically, Revenue has averaged -$435354275.9 billion across 5 years, with a median of $42316.4 in 2021.
  • The sharpest annual moves came in 2021 and 2024: Revenue surged 11389249.91% in 2021, then tumbled 110890976120175.95% in 2024.
  • A 5-year view of Revenue shows it stood at $0.01 in 2020, then soared by 11389249.91% to $1690.7 in 2021, then soared by 34421.0% to $583646.0 in 2022, then soared by 303.6% to $2.4 million in 2023, then sank by 110890976120175.95% to -$2612125655.3 billion in 2024.
  • The last three Revenue figures came in at -$2612125655.3 billion (Q4 2024), $2.4 million (Q4 2023), and $82942.2 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,612,125,655.29 Bn
Dec 31, 2023 2.36 Mn
Jun 30, 2023 82,942.19
Dec 31, 2022 583,646.00
Dec 31, 2021 1,690.70
Dec 31, 2020 0.01
Dec 31, 2019 15,566.23
Dec 31, 2018 978,233.00
Dec 31, 2017 716,323.37
Dec 31, 2016 530,121.20
Jun 30, 2016 862,831.81